BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27365492)

  • 1. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
    Canvin M; Sinka K; Hughes G; Mesher D
    Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study.
    Howell-Jones R; Soldan K; Wetten S; Mesher D; Williams T; Gill ON; Hughes G
    J Infect Dis; 2013 Nov; 208(9):1397-403. PubMed ID: 24092908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M; Mesher D; Mohammed H; Soldan K
    Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
    Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
    Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
    Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
    Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.
    Sonnenberg P; Tanton C; Mesher D; King E; Beddows S; Field N; Mercer CH; Soldan K; Johnson AM
    Sex Transm Infect; 2019 Aug; 95(5):386-390. PubMed ID: 30723185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
    Szarewski A; Skinner SR; Garland SM; Romanowski B; Schwarz TF; Apter D; Chow SN; Paavonen J; Del Rosario-Raymundo MR; Teixeira JC; De Carvalho NS; Castro-Sanchez M; Castellsagué X; Poppe WA; De Sutter P; Huh W; Chatterjee A; Tjalma WA; Ackerman RT; Martens M; Papp KA; Bajo-Arenas J; Harper DM; Torné A; David MP; Struyf F; Lehtinen M; Dubin G
    J Infect Dis; 2013 Nov; 208(9):1391-6. PubMed ID: 24092907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    Dominiak-Felden G; Gobbo C; Simondon F
    PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
    Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS
    Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.